Dr. Simons
Sources: the KBO register on 17-11-2026; the National Bank, 2025 annual accounts filed on 23-04-2026; the Belgian Official Gazette, latest deed of 22-05-2020.
Grounds
the facts the verdict rests on, each with its source- Dr. Simons made a profit in every financial year since 2020. The profit of 2025, €124,663, is the highest so far.Annual accounts 2020 to 2025 page 2
- Equity stands at €7,336, or 4.5% of the balance sheet total of €163,301.Annual accounts 2025 page 2
- Dr. Simons paid out €240,000 in dividends, 193% of the profit of 2025. Because of the dividend and higher debts to suppliers, solvency fell from 80.9% to 4.5%.Annual accounts 2025 page 2
- The last five annual accounts came in on time. The 2025 accounts were filed 99 days before the end of the term.National Bank, filing of 23-04-2026 page 4
Representation
Checked did not find the signing rule in the deeds it read.
Ownership
The accounts in the micro format list no shareholders. holds 250 shares. According to the deed of 22-05-2020, holds all the shares.
Deed of 22-05-2020, deed 20322814
Financial situation
Annual accounts 2021 to 2025, as filed with the National Bank
Gross margin and net resultin euro
Equity and debtsin euro
Cashin euro
| Financial year | 2021 | 2022 | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|---|---|
| Results | ||||||
| Gross margin | €125,159 | €131,023 | €165,891 | €160,933 | €175,421 | |
| Operating result | €122,968 | €129,056 | €164,306 | €157,792 | €162,776 | |
| Net result | €96,111 | €96,477 | €121,425 | €117,141 | €124,663 | |
| Balance sheet at the closing date | ||||||
| Equity | €174,231 | €269,108 | €125,533 | €122,673 | €7,336 | |
| Debts | €3,736 | €7,363 | €17,039 | €28,929 | €155,965 | |
| Debts due after more than one year | - | - | - | - | €19,538 | |
| Debts due within one year | €3,736 | €7,363 | €17,039 | €28,929 | €136,427 | |
| Cash | €132,975 | €189,940 | €36,476 | €50,987 | €56,169 | |
| Balance sheet total | €177,967 | €276,471 | €142,572 | €151,602 | €163,301 | |
| Ratios | ||||||
| Solvency | 97.9% | 97.3% | 88.0% | 80.9% | 4.5% | |
| Liquidity | 45.17 | 36.54 | 8.01 | 4.94 | 0.76 | |
Source: Annual accounts 2025, micro format, filed on 23-04-2026 (2026-00087295); Annual accounts 2024, micro format, filed on 02-07-2025 (2025-00225838); Annual accounts 2021 to 2023, filed from 11-07-2022 to 01-07-2024 (2022-20168170, 2023-00215885, 2024-00219971).
Debts rose by €127,036 in 2025, of which €639 to suppliers. A dividend stands among the debts on the balance sheet date until it is paid.
The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.
Dr. Simons states no turnover; the micro format does not require it. The gross margin, what is left after purchases, rose from €160,933 to €175,421.
Board, signature and ownership
Position on 17-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
Checked did not find the signing rule in the deeds it read.
Board
one director in officeOwnership and group
Shareholders
The accounts in the micro format list no shareholders. holds 250 shares. According to the deed of 22-05-2020, holds all the shares.
Deed of 22-05-2020, deed 20322814
Events and comparison
Every event since the founding, newest first
Annual accounts 2025 filed, 99 days before the deadline.
NBB filingHighest result from 2020 to 2025. The net result of €124,663 is the highest of those years.
FinancialAnnual accounts 2024 filed, 29 days before the deadline.
NBB filingAnnual accounts 2023 filed, 30 days before the deadline.
NBB filingAnnual accounts 2022 filed, 26 days before the deadline.
NBB filingEquity above €200,000. With a profit in every financial year since 2020, equity grows to €269,108.
FinancialAnnual accounts 2021 filed, 20 days before the deadline.
NBB filingEquity above €150,000. With a profit in every financial year since 2020, equity grows to €174,231.
FinancialAnnual accounts 2020 filed, 11 days before the deadline.
NBB filingIncorporation. Founding capital of €2,500, 250 shares. Founded by (comparant). appointed as director. Published on 22-05-2020.
Gazette, deed 20322814First establishment. Diksmuidelei 24, Brasschaat.
Comparable companies, two years later
In July 2024, 2,154 companies had the same profile as Dr. Simons has now: micro, 5 to 10 years old, solvency under 10% and a profit of 5% of the balance sheet or more. Two years later 96.0% were still trading, 2.4% had stopped another way and 1.7% had gone bankrupt.
Other findings
Peppol
Not listed in the Peppol Directory.
Sanctions lists
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 17-11-2026 | KBO 0747.475.268 |
| National Bank of Belgium | Annual accounts 2025, micro format | 23-04-2026 | 2026-00087295 |
| National Bank of Belgium | Annual accounts 2024, micro format | 02-07-2025 | 2025-00225838 |
| National Bank of Belgium | Annual accounts 2021 to 2023 | 11-07-2022 to 01-07-2024 | 2022-20168170, 2023-00215885, 2024-00219971 |
| Belgian Official Gazette | All shares held by one shareholder | 22-05-2020 | deed 20322814 |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 16-11-2026 | no match |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 16-11-2026 | bankruptcy model of 2 October 2026 |
Method
Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 16-11-2026.
Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.
Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.
Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.
The scores and ratios are Checked's own calculations, not a credit decision.